General Announcement-Minutes of Extraordinary General Meeting Held on 10 March 2025

Mar 26 05:27 ET

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-Disclosure of Interest/ Changes in Interest of Director - Patrick Donald Davies

Mar 24 05:26 ET

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-Disclosure of Interest/ Changes in Interest of Director - Teo Woon Keng John

Mar 24 05:25 ET

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung

Mar 24 05:23 ET

General Announcement-Issuance and Allotment of Directors' Shares

Mar 21 05:51 ET

IX Biopharma: REPL-Extraordinary/ Special General Meeting-Voluntary

Mar 10 05:40 ET

IX Biopharma: Extraordinary/ Special General Meeting-Voluntary

Feb 21 20:00 ET

IX Biopharma: Equity Listing - Ordinary Shares-Issue and Allotment of New Shares Pursuant to iX Performance Share Plan

Feb 21 04:34 ET

General Announcement-Proposed Appointment of Auditors and Proposed Issuance of Shares to Directors

Feb 20 06:16 ET

Employee Stock Option/ Share Scheme-Grant of Share Awards Pursuant to iX Performance Share Plan

Feb 14 06:16 ET

General Announcement-Press Release - iX Biopharma Delivers 39% Revenue Growth in 1H25, Reduces Operating Cash Burn by 33%

Feb 7 04:34 ET

Financial Statements and Related Announcement-Half Yearly Results

Feb 7 04:30 ET

General Announcement-Press Release - iXB 401 Achieves 20x Higher Bioavailability Than Rybelsus in Preclinical Study

Nov 19, 2024 04:46 ET

General Announcement-Minutes of Extraordinary General Meeting Held on 17 October 2024

Nov 15, 2024 05:00 ET

General Announcement-Minutes of Annual General Meeting Held on 17 October 2024

Nov 15, 2024 04:57 ET

General Announcement-Formation of the Audit and Risk Committee and Reconstitution of the Board Committees

Oct 17, 2024 07:06 ET

IX Biopharma: REPL-Extraordinary/ Special General Meeting-Voluntary

Oct 17, 2024 07:00 ET

IX Biopharma: REPL-Annual General Meeting-Voluntary

Oct 17, 2024 06:53 ET

General Announcement-Press Release - iX Biopharma Appoints Dr. Brian Kennedy as New Scientific Advisor

Oct 14, 2024 05:39 ET

IX Biopharma: Extraordinary/ Special General Meeting-Voluntary

Sep 30, 2024 18:49 ET